TY - JOUR AU - Liang, S. B. AU - Wang, Y. AU - Hu, X. F. AU - He, S. S. AU - Yang, X. L. AU - Liu, L. Z. PY - 2017 DA - 2017// TI - Survival and toxicities of IMRT based on the RTOG protocols in patients with nasopharyngeal carcinoma from the endemic regions of China JO - J Cancer VL - 8 UR - https://doi.org/10.7150/jca.20351 DO - 10.7150/jca.20351 ID - Liang2017 ER - TY - JOUR AU - Bhattacharyya, T. AU - Babu, G. AU - Kainickal, C. T. PY - 2018 DA - 2018// TI - Current role of chemotherapy in nonmetastatic nasopharyngeal Cancer JO - J Oncol VL - 2018 UR - https://doi.org/10.1155/2018/3725837 DO - 10.1155/2018/3725837 ID - Bhattacharyya2018 ER - TY - JOUR AU - Yan, H. AU - Cao, X. AU - Wang, J. PY - 2017 DA - 2017// TI - Application of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma JO - Oncol Lett VL - 14 UR - https://doi.org/10.3892/ol.2017.6564 DO - 10.3892/ol.2017.6564 ID - Yan2017 ER - TY - JOUR AU - Peng, H. AU - Chen, L. AU - Zhang, J. AU - Li, W. F. AU - Mao, Y. P. AU - Zhang, Y. PY - 2017 DA - 2017// TI - Induction chemotherapy improved Long-term outcomes of patients with Locoregionally advanced nasopharyngeal carcinoma: a propensity matched analysis of 5-year survival outcomes in the era of intensity-modulated radiotherapy JO - J Cancer VL - 8 UR - https://doi.org/10.7150/jca.16732 DO - 10.7150/jca.16732 ID - Peng2017 ER - TY - JOUR AU - Ribassin-Majed, L. AU - Marguet, S. AU - Lee, A. W. M. AU - Ng, W. T. AU - Ma, J. AU - Chan, A. T. C. PY - 2017 DA - 2017// TI - What is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2016.67.4119 DO - 10.1200/JCO.2016.67.4119 ID - Ribassin-Majed2017 ER - TY - JOUR AU - Chen, Y. P. AU - Tang, L. L. AU - Yang, Q. AU - Poh, S. S. AU - Hui, E. P. AU - Chan, A. T. C. PY - 2018 DA - 2018// TI - Induction chemotherapy plus concurrent Chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trials JO - Clin Cancer Res VL - 24 UR - https://doi.org/10.1158/1078-0432.CCR-17-2656 DO - 10.1158/1078-0432.CCR-17-2656 ID - Chen2018 ER - TY - JOUR AU - Lang, J. AU - Gao, L. AU - Guo, Y. AU - Zhao, C. AU - Zhang, C. PY - 2014 DA - 2014// TI - Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013 JO - Future Oncol VL - 10 UR - https://doi.org/10.2217/fon.14.44 DO - 10.2217/fon.14.44 ID - Lang2014 ER - TY - JOUR AU - Skulsky, S. L. AU - O'Sullivan, B. AU - McArdle, O. AU - Leader, M. AU - Roche, M. AU - Conlon, P. J. PY - 2017 DA - 2017// TI - Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American joint committee on Cancer and NCCN clinical practice guidelines in oncology JO - Head Neck VL - 39 UR - https://doi.org/10.1002/hed.24580 DO - 10.1002/hed.24580 ID - Skulsky2017 ER - TY - JOUR AU - Kim, R. AU - Hahn, S. AU - Shin, J. AU - Ock, C. Y. AU - Kim, M. AU - Keam, B. PY - 2016 DA - 2016// TI - The effect of induction chemotherapy using Docetaxel, Cisplatin, and fluorouracil on survival in locally advanced head and neck squamous cell carcinoma: a meta-analysis JO - Cancer Res Treat VL - 48 UR - https://doi.org/10.4143/crt.2015.359 DO - 10.4143/crt.2015.359 ID - Kim2016 ER - TY - JOUR AU - Zeng, Z. AU - Yan, R. N. AU - Tu, L. AU - Wang, Y. Y. AU - Chen, P. R. AU - Luo, F. PY - 2018 DA - 2018// TI - Assessment of concurrent Chemoradiotherapy plus induction chemotherapy in advanced nasopharyngeal carcinoma: Cisplatin, fluorouracil, and Docetaxel versus gemcitabine and Cisplatin JO - Sci Rep VL - 8 UR - https://doi.org/10.1038/s41598-018-33614-5 DO - 10.1038/s41598-018-33614-5 ID - Zeng2018 ER - TY - JOUR AU - Sun, Y. AU - Li, W. F. AU - Chen, N. Y. AU - Zhang, N. AU - Hu, G. Q. AU - Xie, F. Y. PY - 2016 DA - 2016// TI - Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30410-7 DO - 10.1016/S1470-2045(16)30410-7 ID - Sun2016 ER - TY - JOUR AU - Kawahira, M. AU - Yokota, T. AU - Hamauchi, S. AU - Onozawa, Y. AU - Ogawa, H. AU - Onoe, T. PY - 2017 DA - 2017// TI - Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal stage N2-3 JO - Jpn J Clin Oncol VL - 47 UR - https://doi.org/10.1093/jjco/hyx057 DO - 10.1093/jjco/hyx057 ID - Kawahira2017 ER - TY - JOUR AU - Kong, L. AU - Zhang, Y. AU - Hu, C. AU - Guo, Y. AU - Lu, J. J. PY - 2017 DA - 2017// TI - Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: final results of 2 parallel phase 2 clinical trials JO - Cancer VL - 123 UR - https://doi.org/10.1002/cncr.30566 DO - 10.1002/cncr.30566 ID - Kong2017 ER - TY - JOUR AU - Herbst, R. S. AU - Shin, D. M. PY - 2002 DA - 2002// TI - Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy JO - Cancer VL - 94 UR - https://doi.org/10.1002/cncr.10372 DO - 10.1002/cncr.10372 ID - Herbst2002 ER - TY - JOUR AU - Sun, W. AU - Long, G. AU - Wang, J. AU - Mei, Q. AU - Liu, D. AU - Hu, G. PY - 2014 DA - 2014// TI - Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: a meta-analysis JO - Head Neck VL - 36 UR - https://doi.org/10.1002/hed.23355 DO - 10.1002/hed.23355 ID - Sun2014 ER - TY - JOUR AU - Ma, X. AU - Huang, J. AU - Wu, X. AU - Li, X. AU - Zhang, J. AU - Xue, L. PY - 2014 DA - 2014// TI - Epidermal growth factor receptor could play a prognostic role to predict the outcome of nasopharyngeal carcinoma: a meta-analysis JO - Cancer Biomark VL - 14 UR - https://doi.org/10.3233/CBM-140401 DO - 10.3233/CBM-140401 ID - Ma2014 ER - TY - JOUR AU - Ma, B. B. AU - Poon, T. C. AU - To, K. F. AU - Zee, B. AU - Mo, F. K. AU - Chan, C. M. PY - 2003 DA - 2003// TI - Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study JO - Head Neck VL - 25 UR - https://doi.org/10.1002/hed.10307 DO - 10.1002/hed.10307 ID - Ma2003 ER - TY - JOUR AU - Peng, H. AU - Tang, L. L. AU - Liu, X. AU - Chen, L. AU - Li, W. F. AU - Mao, Y. P. PY - 2018 DA - 2018// TI - Anti-epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma JO - Cancer Sci VL - 109 UR - https://doi.org/10.1111/cas.13589 DO - 10.1111/cas.13589 ID - Peng2018 ER - TY - JOUR AU - Wang, Y. AU - Pan, L. AU - Sheng, X. F. AU - Chen, S. AU - Dai, J. Z. PY - 2016 DA - 2016// TI - Nimotuzumab, a humanized monoclonal antibody specific for the EGFR, in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma multiforme: first results in Chinese patients JO - Asia Pac J Clin Oncol VL - 12 UR - https://doi.org/10.1111/ajco.12166 DO - 10.1111/ajco.12166 ID - Wang2016 ER - TY - JOUR AU - Chong, D. Q. AU - Toh, X. Y. AU - Ho, I. A. AU - Sia, K. C. AU - Newman, J. P. AU - Yulyana, Y. PY - 2015 DA - 2015// TI - Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1191-3 DO - 10.1186/s12885-015-1191-3 ID - Chong2015 ER - TY - JOUR AU - Wang, F. AU - Jiang, C. AU - Ye, Z. AU - Sun, Q. AU - Liu, T. AU - Xu, M. PY - 2017 DA - 2017// TI - Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma JO - Oncotarget VL - 8 ID - Wang2017 ER - TY - JOUR AU - Liu, Z. G. AU - Zhao, Y. AU - Tang, J. AU - Zhou, Y. J. AU - Yang, W. J. AU - Qiu, Y. F. PY - 2016 DA - 2016// TI - Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis JO - Oncotarget VL - 7 ID - Liu2016 ER - TY - JOUR AU - Huang, J. AU - Zou, Q. AU - Qian, D. AU - Zhou, L. AU - Yang, B. AU - Chu, J. PY - 2017 DA - 2017// TI - Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma JO - Onco Targets Ther VL - 10 UR - https://doi.org/10.2147/OTT.S151554 DO - 10.2147/OTT.S151554 ID - Huang2017 ER - TY - JOUR AU - Chua, D. T. AU - Nicholls, J. M. AU - Sham, J. S. AU - Au, G. K. PY - 2004 DA - 2004// TI - Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy JO - Int J Radiat Oncol Biol Phys VL - 59 UR - https://doi.org/10.1016/j.ijrobp.2003.10.038 DO - 10.1016/j.ijrobp.2003.10.038 ID - Chua2004 ER - TY - JOUR AU - Ou, D. AU - Blanchard, P. AU - El, K. C. AU - De, F. F. AU - Even, C. AU - Levy, A. PY - 2016 DA - 2016// TI - Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinoma JO - Oral Oncol VL - 62 UR - https://doi.org/10.1016/j.oraloncology.2016.10.011 DO - 10.1016/j.oraloncology.2016.10.011 ID - Ou2016 ER - TY - JOUR AU - Tian, R. AU - Ye, H. X. AU - Zhang, B. G. AU - Gu, D. Y. AU - Zhang, B. W. AU - Teng, Z. P. PY - 2015 DA - 2015// TI - Use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis JO - Onco Targets Ther VL - 8 ID - Tian2015 ER - TY - JOUR AU - Peng, L. AU - Liu, Z. L. AU - Xu, C. AU - Tang, L. L. AU - Liu, X. AU - Lin, A. H. PY - 2018 DA - 2018// TI - The efficacy and safety of anti-epidermal growth factor receptor monoclonal antibodies in nasopharyngeal carcinoma: literature-based meta-analyses JO - J Cancer VL - 9 UR - https://doi.org/10.7150/jca.27611 DO - 10.7150/jca.27611 ID - Peng2018 ER - TY - JOUR AU - Peng, H. AU - Tang, L. L. AU - Liu, X. AU - Chen, L. AU - Li, W. F. AU - Mao, Y. P. PY - 2018 DA - 2018// TI - Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis JO - BMC Cancer VL - 18 UR - https://doi.org/10.1186/s12885-018-4268-y DO - 10.1186/s12885-018-4268-y ID - Peng2018 ER - TY - JOUR AU - Lin, M. AU - You, R. AU - Liu, Y. P. AU - Zhang, Y. N. AU - Zhang, H. J. AU - Zou, X. PY - 2018 DA - 2018// TI - Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma JO - Oral Oncol VL - 80 UR - https://doi.org/10.1016/j.oraloncology.2018.03.002 DO - 10.1016/j.oraloncology.2018.03.002 ID - Lin2018 ER - TY - JOUR AU - You, R. AU - Hua, Y. J. AU - Liu, Y. P. AU - Yang, Q. AU - Zhang, Y. N. AU - Li, J. B. PY - 2017 DA - 2017// TI - Concurrent Chemoradiotherapy with or without anti-EGFR-targeted treatment for stage II-IVb nasopharyngeal carcinoma: retrospective analysis with a large cohort and Long follow-up JO - Theranostics VL - 7 UR - https://doi.org/10.7150/thno.19710 DO - 10.7150/thno.19710 ID - You2017 ER - TY - JOUR AU - Zhang, Y. AU - Chen, L. AU - Hu, G. Q. AU - Zhang, N. AU - Zhu, X. D. AU - Yang, K. Y. PY - 2019 DA - 2019// TI - Gemcitabine and Cisplatin induction chemotherapy in nasopharyngeal carcinoma JO - N Engl J Med VL - 381 UR - https://doi.org/10.1056/NEJMoa1905287 DO - 10.1056/NEJMoa1905287 ID - Zhang2019 ER -